Protocol core biopsy (CADI): a surrogate marker for chronic rejection. Mycophenolate Mofetil ICM 1866 and IICR 023 Study Groups.
Yilmaz
S
S
Transplantation Laboratory, University of Helsinki, and Helsinki University Central Hospital, Helsinki, Finland.
Taskinen
E
E
Paavonen
T
T
Häyry
P
P
D001706:Biopsy; D002908:Chronic Disease; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000473:pathology*; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000276:immunology / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology*; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D012044:Regression Analysis; D012307:Risk Factors; D013997:Time Factors; D014184:Transplantation, Homologous / Q000473:pathology
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid